These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8333238)

  • 1. Cerebrospinal fluid and MRI findings in three patients with multiple sclerosis and systemic lupus erythematosus.
    Kinnunen E; Müller K; Keto P; Ketonen L; Helve T; Sepponen R
    Acta Neurol Scand; 1993 May; 87(5):356-60. PubMed ID: 8333238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid.
    Warren KG; Catz I
    J Neurol Sci; 1994 Jan; 121(1):66-73. PubMed ID: 7510787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.
    Cramer SP; Modvig S; Simonsen HJ; Frederiksen JL; Larsson HB
    Brain; 2015 Sep; 138(Pt 9):2571-83. PubMed ID: 26187333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis.
    Frederiksen JL; Larsson HB; Olesen J
    Acta Neurol Scand; 1992 Sep; 86(3):317-22. PubMed ID: 1414254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis.
    McLean BN; Zeman AZ; Barnes D; Thompson EJ
    J Neurol Neurosurg Psychiatry; 1993 Apr; 56(4):356-60. PubMed ID: 8482955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation of cerebrospinal fluid protein assays in various neurologic diseases.
    Christenson RH; Behlmer P; Howard JF; Winfield JB; Silverman LM
    Clin Chem; 1983 Jun; 29(6):1028-30. PubMed ID: 6851088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic neuritis: findings on MRI, CSF examination and HLA class II typing in 60 patients and results of a short-term follow-up.
    Söderström M; Lindqvist M; Hillert J; Käll TB; Link H
    J Neurol; 1994 May; 241(6):391-7. PubMed ID: 7931435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebrospinal fluid IgG and the blood-brain barrier in multiple sclerosis. A new viewpoint].
    Rüttinger H; Rüttinger P; Hermes M
    Nervenarzt; 1991 Feb; 62(2):127-9. PubMed ID: 2034308
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity.
    Hirohata S; Hirose S; Miyamoto T
    Arch Intern Med; 1985 Oct; 145(10):1843-6. PubMed ID: 3899036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Tumani H; Tourtellotte WW; Peter JB; Felgenhauer K
    J Neurol Sci; 1998 Feb; 155(1):44-9. PubMed ID: 9562321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system.
    McLean BN; Miller D; Thompson EJ
    J Neurol Neurosurg Psychiatry; 1995 May; 58(5):548-54. PubMed ID: 7745401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren's syndrome.
    Kim SS; Richman DP; Johnson WO; Hald JK; Agius MA
    Mult Scler; 2014 Jan; 20(1):57-63. PubMed ID: 23736535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic value of nuclear magnetic resonance tomography, multimodal evoked potentials and cerebrospinal fluid examination in multiple sclerosis].
    Staffen W; Trinka E; Ladurner G
    Nervenarzt; 1993 Apr; 64(4):226-32. PubMed ID: 8506010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of increased levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) in the cerebrospinal fluid of patients with multiple sclerosis and systemic lupus erythematosus.
    Baraczka K; Pozsonyi T; Szongoth M; Nékám K; Megyeri A; Balogh Z; Jakab L
    Acta Neurol Scand; 1999 Feb; 99(2):95-9. PubMed ID: 10071167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus antibody levels in the cerebrospinal fluid from patients with optic neuritis.
    Nikoskelainen E; Nikoskelainen J; Salmi AA; Halonen PE
    Acta Neurol Scand; 1975 May; 51(5):347-64. PubMed ID: 165653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis.
    Jacobs LD; Kaba SE; Miller CM; Priore RL; Brownscheidle CM
    Ann Neurol; 1997 Mar; 41(3):392-8. PubMed ID: 9066361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests.
    West SG; Emlen W; Wener MH; Kotzin BL
    Am J Med; 1995 Aug; 99(2):153-63. PubMed ID: 7625420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus.
    Golombek SJ; Graus F; Elkon KB
    Arthritis Rheum; 1986 Sep; 29(9):1090-7. PubMed ID: 3753538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis--making the diagnosis.
    Hallpike J
    Aust Fam Physician; 1992 Oct; 21(10):1407-10. PubMed ID: 1444966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of systemic lupus erythematosus--its clinical and MRI resemblance to multiple sclerosis.
    Moriwaka F; Tashiro K; Fukazawa T; Akino M; Yasuda I; Sagawa A; Hida K
    Jpn J Psychiatry Neurol; 1990 Sep; 44(3):601-5. PubMed ID: 2074620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.